TGFB3 and head and neck squamous cell carcinoma: In this screen, TGF-β3 was significantly more abundant in the plasma EVs of HNSCC patients that did not respond to chemo-radiation treatment and the high levels of TGF-β3 in plasma EVs was associated with poor progression-free survival, highlighting the relevance of the use of EV-based biomarkers in oncology.